Navigation Links
Republican sees nothing wrong with Doyle's use of executive order

Brookfield, Wis. A key lawmaker who often disagrees with Governor Jim Doyle on embryonic stem cell research said Wednesday that he saw nothing inappropriate about the governor's use of an executive order as an instrument to fund the recruiting of stem cell companies.

Meanwhile, the executive order, signed Tuesday at the Medical College of Wisconsin, drew a sharp rebuke from the di......

Full article >>> executive order, Doyle cited the potential of stem cell research to help scientists find therapies for life-threatening and debilitating diseases such as cancer, Parkinson's, Alzheimer's, and diabetes. The governor's mother suffers from Parkinson's disease, and while he acknowledged Tuesday that stem cell research probably won't help her, he said it has the potential to help future generations.
Full article >>>
'"/>

Source:wistechnology.com By Joe Vanden Plas 04/27/06


Related biology technology :

1. Republicans propose sweeping changes to promote investment
2. Republicans criticize Doyles growth package
3. No network infrastructure, no Olympics, no nothing
4. Bridging the digital divide is the wrong battle cry
5. Chemical-petroleum executive joins Virent Energy board
6. Visions: Matheys says CIO role is good training for executive suite
7. Biotech executive books a career flight thats closer to home
8. CEOs Gone Wild? Risks and rewards in the executive suite
9. Early-stage executives hear from investors
10. Pedlar the latest executive to leave Merge
11. Financial executives to launch Madison chapter
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/8/2016)... This report analyzes the worldwide markets for Biostimulants ... Amino, & Fulvic), Extract Based, and Others. The report also ... & Turf, Row Crops, and Others. The report provides separate ... Japan , Europe , ... , and Rest of World. Annual estimates and forecasts are ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... of innovation is taking over sports. On Thursday, December 15th a panel of ... is disrupting the playing field at a Smart Talk session. Smart Talk will ...
(Date:12/8/2016)... 8, 2016  Renova™ Therapeutics, a biotechnology company ... and type 2 diabetes, announced that it has ... virus (AAV) vector developed in the laboratory of ... Stanford University. The company plans to use this ... product pipeline. "Early research has ...
(Date:12/8/2016)... Portland, Oregon (PRWEB) , ... December 08, 2016 ... ... modules and the FrontPanel SDK that provide essential device-to-computer interconnect using USB or ... do not require FrontPanel support. The FOMD-ACV-A4 is a small, thin, SODIMM-style module ...
Breaking Biology Technology:
(Date:11/29/2016)... -- BioDirection, a privately held medical device company developing ... of concussion and other traumatic brain injury (TBI), announced ... with the U.S. Food and Drug Administration (FDA) to ... the meeting company representatives reviewed plans for clinical development ... of a planned pilot trial. "We ...
(Date:11/24/2016)... 2016 Cercacor today introduced Ember TM ... non-invasively measure hemoglobin, Oxygen Content, Oxygen Saturation, ... Rate in approximately 30 seconds. Smaller than a smartphone, ... access to key data about their bodies to help ... Hemoglobin carries oxygen to muscles. When ...
(Date:11/19/2016)... , Nov. 18, 2016 Securus Technologies, ... solutions for public safety, investigation, corrections and monitoring, announced ... smaller competitor, ICSolutions, to have an independent technology judge ... the most modern high tech/sophisticated telephone calling platform, and ... customers that they do most of what we do ...
Breaking Biology News(10 mins):